Target intelligence / Profile preview

Schlafen family member 12 (SLFN12)

Target
SLFN12
Molecular classification
Cytosolic protein, Ribonuclease
01

Overview

Schlafen family member 12 (SLFN12) is a cytosolic protein that plays a role in various cellular processes, including cell proliferation, differentiation, immune response modulation, and inhibition of viral replication. It is involved in stimulating the expression of sucrase-isomaltase and modulates sensitivity to DNA-damaging agents. SLFN12 functions as part of an E2/17β‐estradiol-induced pro-apoptotic signaling pathway and is linked with autoimmune diseases and cancer progression.

02

Mechanism of action

E2/estradiol-induced apoptosis via PDE3A complex stabilization

03

Biological functions

Stimulates sucrase-isomaltase expressionAnti-proliferationCell differentiationInhibition of viral replicationRegulation of apoptosisModulates DNA damage sensitivity
04

Disease associations

Multiple sclerosisCancer progression/metastasisBleeding Disorder, Platelet-Type, 20Asthma phenotypes
05

Safety considerations

Potential impact on chemotherapy/radiotherapy efficacy due to modulation of DNA damage sensitivity
06

Biomarkers

Airway epithelial responses (asthma phenotyping)

Beyond the preview

Go deeper on Schlafen family member 12 (SLFN12).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Schlafen family member 12 (SLFN12).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call